UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Insurance coverage of immunotherapeutic anticancer drug gains momentum
Much to the relief of cancer patients, the moves toward the insurance cover...
by Park Gi-taek
|
2017-04-13 16:50
라인
I asked a foreign doctor about Remsima and…
Is Celltrion’s biosimilar Remsima safe and effective?It may be a stupid que...
by Park Gi-taek
|
2017-03-30 14:55
라인
'Amgen Korea will win global recognition soon'
One and a half year have passed since Amgen, a role model for Korean bio an...
by Park Gi-taek
|
2017-03-13 18:30
라인
Novartis’ leukemia treatment embroiled in efficacy dispute
“Tasigna” – the chronic myeloid leukemia therapy of Novartis which wo...
by Park Gi-taek and Lee Hye-seon
|
2017-03-13 09:21
라인
Pfizer Korea’s antismoke drug sales soar
The sales of Champix, Pfizer Korea’s antismoking drug, entered into the 40 ...
by Park Gi-taek
|
2017-03-06 12:30
라인
Drug makers jittery about illegal lobby scandal
The domestic pharmaceutical industry is keeping a close watch on the suspec...
by Park Gi-taek
|
2017-03-03 18:24
라인
Korea Inc. goes all out to lead bio, pharmaceutical industries
The Korean government and businesses are going to great length to promote b...
by Park Gi-taek and Lee Hye-seon
|
2017-02-22 09:00
라인
Why Does BMS Compare Opdivo with Placebo?
People pay much attention to and have interests in immunotherapy for cancer...
by Park Gi-taek
|
2017-02-08 14:33
라인
“It’s More Dangerous Not to Prescribe Statin Because of the Possible Outbreak of Diabetes”
Experts released the statement about Statin that has caused the possible ou...
by Park Gi-taek
|
2017-01-20 08:52
라인
Takeda Pharmaceuticals Korea, Labor-Management Conflict
The Takeda Pharmaceuticals Korea Co., Ltd is in trouble because of conflict...
by Park Gi-taek
|
2017-01-13 16:15
라인
AMC-MS Korea Open Medical Big Data Platform
The big data center at Asan Medical Center(Seoul Asan Hospital) and Microso...
by Park Gi-taek
|
2017-01-05 09:21
라인
Myongji hospital, developing stem cells etc.…Opening a Cell Treatment Center
Myongji hospital opened the cell treatment center and started their researc...
by Park Gi-taek
|
2016-12-19 09:29
라인
Patients with Dementia needs to have a place to enjoy
Currently the number of domestic patients with dementia has come close to a...
by Park Gi-taek
|
2016-12-19 09:15
라인
The handicapped wearing robot suits will be available soon
A patient who is completely paralyzed below waist and can walk with the hel...
by Park Gi-taek
|
2016-12-13 10:35
라인
Angry Sanofi Labor Union's Upcoming Strikes
“Does 1% salary increase ratio make sense for the top company in terms of o...
by Park Gi-taek
|
2016-12-08 08:32
-
1
2
3
4
5
6
7
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top